[HTML][HTML] Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

EPK Parker, S Desai, M Marti, H Nohynek… - The Lancet Global …, 2022 - thelancet.com
Individuals with compromised immune systems, whether because of immunodeficiency or
immuno suppressive therapy, are among those most susceptible to COVID19. In fact, people …

Causes of impaired oral vaccine efficacy in developing countries

EPK Parker, S Ramani, BA Lopman, JA Church… - Future …, 2018 - Future Medicine
Oral vaccines are less immunogenic when given to infants in low-income compared with
high-income countries, limiting their potential public health impact. Here, we review factors that …

The epidemiology of non-polio enteroviruses: recent advances and outstanding questions

M Pons-Salort, EPK Parker… - Current opinion in …, 2015 - journals.lww.com
Reported outbreaks of respiratory, neurological, skin and eye diseases associated with human
enteroviruses have increased in frequency and size in recent years. Improved molecular …

[HTML][HTML] Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study

NC Grassly, M Pons-Salort, EPK Parker… - The Lancet Infectious …, 2020 - thelancet.com
Background WHO has called for increased testing in response to the COVID-19 pandemic,
but countries have taken different approaches and the effectiveness of alternative strategies …

[HTML][HTML] An interactive website tracking COVID-19 vaccine development

…, T Swinnen, B Kampmann, EPK Parker - The Lancet Global …, 2021 - thelancet.com
The past year has seen the rapid global spread of SARS-CoV-2—the virus responsible for
the ongoing COVID-19 pandemic. While non-pharmaceutical inter ventions have been the …

[HTML][HTML] Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the …

L Nab, EPK Parker, CD Andrews, WJ Hulme… - The Lancet public …, 2023 - thelancet.com
Background COVID-19 has been shown to differently affect various demographic and
clinical population subgroups. We aimed to describe trends in absolute and relative COVID-19-…

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …

…, L Nab, A Schultze, V Mahalingasivam, EPK Parker… - bmj, 2022 - bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health …

…, RH Keogh, TM Palmer, EJ Williamson, EPK Parker… - bmj, 2022 - bmj.com
… Elsie MF Horne,1,2 William J Hulme,3 Ruth H Keogh,4 Tom M Palmer,1,5 Elizabeth J
Williamson,4 Edward PK Parker,4 Amelia Green,3 Venexia Walker,1,5 Alex J Walker,3 Helen …

Keeping track of the SARS-CoV-2 vaccine pipeline

EPK Parker, M Shrotri, B Kampmann - Nature Reviews Immunology, 2020 - nature.com
This Web Watch introduces the VaC tracker, a web resource that features an overview of the
COVID-19 'vaccine landscape', a clinical trials database and a 'living review'that distils the …

[HTML][HTML] Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India

EPK Parker, I Praharaj, A Zekavati, RP Lazarus, S Giri… - Vaccine, 2018 - Elsevier
Oral rotavirus vaccines have consistently proven to be less immunogenic among infants in
developing countries. Discrepancies in the intestinal microbiota, including a greater burden of …